Regarding CBX5, its upregulation has been associated with increased cell proliferation and poor clinical prognosis [52,53]; furthermore, its downregulation was linked to a higher invasive potential of cancer cells in metastatic cells of colon cancer and thyroid carcinoma compared with non-metastatic cells [53]. Here, CBX5 is linked to colonic neoplasm.